We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Mylan Receives Approvable Letter for Beta-Blocker Nebivolol
Mylan Receives Approvable Letter for Beta-Blocker Nebivolol
June 3, 2005
The FDA has deemed Mylan Laboratories’ beta-blocker nebivolol “approvable” pending successful completion of a preclinical study and finalization of the drug’s labeling, Mylan announced June 1.